Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients

Journal of Hypertension

Volumn 21, Issue 3, 2003, Pages 625-631

  Rizzoni, Damiano ^a   Palombo, Carlo ^c,d   Porteri, Enzo ^a   Muiesan, Maria Lorenza ^a   Kozàkovà, Michaela ^c,d   La Canna, Giovanni ^b   Nardi, Matilde ^b   Guelfi, Daniele ^a   Salvetti, Massimo ^a   Morizzo, Carmela ^c   Vittone, Francesca ^c,d   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Adenosine; Hypertension; Regional blood flow; Remodelling

Indexed keywords

ADENOSINE;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; FEMALE; HUMAN; HYPERTENSION; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUBCUTANEOUS FAT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASODILATATION;

EID: 0037359427     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200303000-00030     Document Type: Article

References (51)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 63:347-504.
2. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921-971.
3. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodelling and growth. Hypertension 1993; 21:391-397.
4. Folkow B, Grimby G, Thulesius O. Adaptive structural changes in the vascular wall in hypertension and their relation to the control of peripheral resistance. Acta Physiol Scand 1958; 44:255-272.
5. Conway J. A vascular abnormality in hypertension: a study of blood flow in the forearm. Circulation 1963; 27:520-529.
6. Vogt M. Motz, Strauer BE. Coronary hemodynamics in hypertensive heart disease. Eur Heart J 1992; 13(suppl D):44-49.
7. Kaski JC. Myocardial ischemia in the hypertensive patient. The role of coronary microcirculation abnormalities. Eur Heart J 1993; 14(suppl J): 32-37.
8. Kozakovà M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29:551-559.
9. Strauer B. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979; 44:999-1006.
10. Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J. Reduction of coronary reserve: A mechanisms for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69:1-7.
11. Tanaka M, Fujiwara H, Onodera T, Wu D, Matsuda M, Hamashima Y. Quantitative analysis of narrowing of intramyocardial small arteries in normal hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75:1130-1139.
12. Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 318:1302-1307.
13. Schwartzkopff B, Motz W, Frenzel H, Voght M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88:993-1003.
14. Scheler S, Motz W, Strauer BE. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol 1994; 73:478-482.
15. Subcommittee G. World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 1999; 17:151-183.
16. Kozȧkovà M, Palombo C, Pratali L, Bigalli G, Marzilli M, Distante A, L'Abbate A. Assessment of coronary reserve by transesophageal Doppler echocardiography. Eur Heart J 1997; 18:514-523.
17. Sahn DJ, Maria A De, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
18. Devereux RB, Roman MJ. Evaluation of Cardiac and vascular structure by echocardiography and other non-invasive techniques. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis and treatment, 2nd edn. New York: Raven Press; 1995, pp. 1069-1085.
19. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
20. Mulvany MJ, Halpern W. Contractile properties of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
21. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854-864.
22. Antony I, Nitemberg A, Foult JM, Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993; 22:514-520.
23. Frohlich D. Cardiac hypertrophy in hypertension. N Engl J Med 1988; 317:831-833.
24. Treasure CB, Klein LI, Vita JA, Manoukian SV, Renvick GH, Selwyn AP, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-dependent relaxation in human coronary resistance vessels. Circulation 1993; 87:86-93.
25. Strauer BE. The coronary circulation in hypertensive heart disease. Hypertension 1984; 6(suppl III):III74-III80.
26. Kobayashi K, Tarazi RC, Lovemberg W, Rakusan K. Coronary blood flow in genetic cardiac hypertrophy. Am J Cardiol 1984; 53:1360-1364.
27. Wabgler RD, Peters KG, Marcus ML, Tomanek RJ. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 1982; 51:10-18.
28. Pichard AD, Gorlin R, Smith H, Ambrose J, Meller J. Coronary flow studies in patients with left ventricular hypertrophy of the hypertensive type: evidence of an impaired coronary vascular reserve. Am J Cardiol 1981; 47:547-554.
29. Schafer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodelling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20:1431-1437.
30. Lever AF. Slow presser mechanisms in hypertension. A role for hypertrophy of resistance vessels? J Hypertens 1986; 4:515-524.
31. Wright CE, Angus JA. Enhanced total peripheral vascular responsiveness in hypertension accord with the amplifier hypothesis. J Hypertens 1999; 17:1687-1696.
32. Izzard AS, Heagerty AM, Leenen FH. The amplifier hypothesis: persisting dissent. J Hypertens 2002; 20:375-377.
33. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 1995; 25:201-206.
34. Hasdai D, Gibbons RJ, Holmes DR Jr, Higane ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96:3390-3395.
35. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodelling in secondary hypertension. Hypertension 1996; 28:785-790.
36. Rizzoni D, Muiesan ML, Porteri E, Salvetti M, Castellano M, Bettoni G, et al. Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 1998; 32: 985-992.
37. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996; 27:1031-1038
38. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91.
39. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
40. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli G, Bettoni G, et al. Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997; 15:197-204.
41. Virdis A, Ghiadeni L, Lucarini A, Di Legge V, Taddei S, Salvetti A. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and etfects of long-term treatment. Am J Hypertens 1996; 9:361-369.
42. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995; 13:341-347.
43. Marcus M, Wright C, Doty D, Eastham C, Laughlin D, Krumm P, et al. Measurements of coronary flow velocity and reactive hyperemia in coronary circulation in humans. Circ Res 1981; 49:877-891.
44. Palombo C, Kezakeva M, Magagna A, Bigalli G, Marizzo C, Ghiadeni L, et al. Early impairment of coronary flow reserve and increase in minimal coronary resistance in borderline hypertensive patients. J Hypertens 2000; 16:453-459.
45. Kozȧkevà M, Galetta F, Gregorini L, Bigalli G, Franzoni F, Giusti C, Palombo C. Coronary vasodilator capacity and epicardial vessel remodelling in physiological and hypertensive hypertrophy. Hypertension 2000; 36:343-349.
46. Ressen JD, Quillen JE, Lepez JAG, Stenberg RG, Talman CL, Winniford MD. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991; 18:485-491.
47. Cerqueira MD, Verani MS, Schwaiger M, Jaekyeong H. Iskandrian AS. Safety profile of Adenoscan stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994; 23:384-389.
48. Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 1991; 18:718-729.
49. Ito N, Isoyama S, Takahashi T, Takishima T. Coronary dilator reserve and morphological changes after relief of pressure overload in rats. J Mol Cell Cardiol 1993; 25:3-14.
50. Kallman EA, Bilgin YM, Haren P van, Suylen RJ van, Saxena PR, Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 1996; 32:1088-1095.
51. Schafer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodelling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20:1431-1437.